MARKET

INM

INM

Inmed Pharmaceuticals Inc
NASDAQ
1.430
+0.040
+2.88%
After Hours: 1.387 -0.043 -2.99% 19:23 12/12 EST
OPEN
1.400
PREV CLOSE
1.390
HIGH
1.480
LOW
1.350
VOLUME
386.61K
TURNOVER
--
52 WEEK HIGH
8.27
52 WEEK LOW
1.130
MARKET CAP
4.01M
P/E (TTM)
-0.1982
1D
5D
1M
3M
1Y
5Y
1D
InMed Provides Update on BayMedica Commercial Business
Newsfile · 2d ago
Weekly Report: what happened at INM last week (1201-1205)?
Weekly Report · 6d ago
InMed Pharmaceuticals Has Received A Notice Of Allowance For A U.S. Patent Titled "CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION (USEFUL FOR NEUROLOGICAL CONDITIONS, MOOD/BEHAVIOR DISORDERS, INFECTIONS, AND CANCERS)"
Benzinga · 12/05 20:59
Weekly Report: what happened at INM last week (1124-1128)?
Weekly Report · 12/01 09:30
Weekly Report: what happened at INM last week (1117-1121)?
Weekly Report · 11/24 09:32
Why Intuit Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Benzinga · 11/21 09:41
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/20 12:05
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/20 11:10
More
About INM
InMed Pharmaceuticals Inc. is a pharmaceutical company. The Company develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

Webull offers InMed Pharmaceuticals Inc stock information, including NASDAQ: INM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INM stock methods without spending real money on the virtual paper trading platform.